Statins are the first-line therapy for atherosclerotic cardiovascular disease (ASCVD) risk reduction. Statins have also been shown to be safe and well-tolerated in properly selected patients, similar ...

The latest European guidelines for the primary prevention of cardiovascular disease appear to reduce the number of patients eligible for statin therapy compared with other international ...

Patients with cardiovascular disease, such as heart disease, stroke or peripheral arterial disease, were significantly more likely to be prescribed guideline-recommended high-intensity statin therapy ...

MINNEAPOLIS, MN - November 24, 2014 - Nearly all individuals in their late 60s and early 70s -- including 100 percent of men -- now qualify for and should consider starting a statin medication to ...

The American Heart Association’s new cardiovascular disease event prediction equations could leave 14.3 million patients ineligible for statin therapy, according to a study published July 29 in JAMA.

Statins recommended for persons with HIV with a 10-year ASCVD risk score of 5 percent or higher; favored for those with risk score below 5 percent. (HealthDay News) — In a clinical guideline issued by ...

Ms. C*, a 53-year-old African American woman living with HIV for almost a decade, inquired about the recently released recommendations for cardiovascular disease prevention among people with HIV (PWH) ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The U.S. Preventive Services Task Force in August ...

(HealthDay News) — European and American guidelines lead to different recommendations for statin therapy, according to a study published online in JACC: Cardiovascular Imaging. Amir A. Mahabadi, MD, ...

Diabetics learn to keep a close watch on their blood sugar. New guidelines say they need to keep just as close an eye on their cholesterol. Find out what physicians are learning about keeping ...

CHICAGO - New guidelines on heart health that sparked fierce debate among U.S. cardiologists last fall could lead 12.8 million more Americans to take cholesterol-lowering statin drugs, U.S.